Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers

2022-06-20| Trials & Approvals

Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers

by Reed Slater

Share To

The FDA posted three new Orphan Drug Designations (ODD) on June 17 for two companies targeting brain cancer, Kazia and VBI, and one company targeting a type of liver cancer, Hepion. An orphan drug is a treatment targeting a disease that affects less than 200,000 people in the United States. All three companies will use the ODD and the associated benefits to further the development of their drugs targeting rare cancers.

It's free! Log in now to read

LATEST

AI’s Promise to Profits: How IBM is Maximizing Business ROI with Accelerated Computing

2025-03-19

Edge Computing: The Next Big Thing in AI and Automation

2025-03-19

Neurosurgery Now: NVIDIA’s Holoscan AI Brings Real-Time 3D Vision to Enhance Surgical Precision at 2025 GTC

2025-03-18

NVIDIA GTC 2025: BioMap’s xTrimo — The AI Model That’s Changing Biotech and Drug Discovery

2025-03-18

AstraZeneca Acquires Cell Therapy Company in $1 Billion Deal to Develop In Vivo Cancer Treatments

2025-03-18

Gene Therapy Achieves Complete Cure for Sickle Cell Anemia in New York Patient

2025-03-17

NICE Recommends New Endometriosis Treatment for NHS Patients

2025-03-14

EVENT

2025-03-17

BIO-Europe Spring 2025

Milan, Italy

2025-04-02

Asia Cell and Gene Therapy Innovation Summit 2025

Shanghai, China

2025-04-21

World Vaccine Congress 2025

Washington, U.S.A

2025-04-21

World Vaccine Congress Washington 2025

Washington, U.S.A

2025-04-25

AACR Annual Meeting 2025

Chicago, U.S.A

2025-04-26

SABPA OC/LA 17th Annual Biomedical Forum

Irvine, California, United States

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog